In 2023, hospital discharges for malignant neoplasm of the bladder per hundred thousand people were highest in Germany at 124.2, followed by Austria and Italy. Eastern European countries like Poland and Slovakia also showed significant discharge rates, with Poland experiencing a 1.73% increase. Meanwhile, Western and Northern European countries, including Iceland, saw more considerable declines, with Iceland marking a decrease of 9.7%. Notably, South Korea experienced a significant rise of 2.08%, contrasting with a 3.02% drop in the United Kingdom. Over five years, most countries experienced slight annual reductions, indicating potential healthcare improvements or policy changes.
Future trends may include increased healthcare advancements leading to earlier detection and treatment, potentially lowering discharge rates. Additionally, demographic changes and healthcare policy adjustments across different nations could influence these rates variably. It's essential to monitor technological developments in healthcare that could further impact these statistics globally.
Top countries in Hospital Discharges for Malignant Neoplasm of Bladder by Country
| # | 10 Countries | Units (Hospital Discharges) Per Hundred Thousand Persons | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 Germany | 124.2 | 2023 | -0.32% | -0.19% | View data |
| 2 | 2 Austria | 110.8 | 2023 | +0.45% | -0.37% | View data |
| 3 | 3 Italy | 107.5 | 2023 | +0.28% | -0.46% | View data |
| 4 | 4 Spain | 89.8 | 2023 | +3.34% | 0% | View data |
| 5 | 5 Poland | 82.6 | 2023 | +4.16% | +1.73% | View data |
| 6 | 6 Slovakia | 76.1 | 2023 | +3.26% | +1.09% | View data |
| 7 | 7 France | 75.8 | 2023 | +0.93% | +0.51% | View data |
| 8 | 8 Norway | 64.8 | 2023 | -1.37% | -0.99% | View data |
| 9 | 9 Belgium | 53.9 | 2023 | -0.19% | -0.73% | View data |
| 10 | 10 Netherlands | 47.8 | 2023 | -0.62% | -2.12% | View data |
